Predictive, preventive and personalised medicine as the hardcore of 'horizon 2020': EPMA position paper

EPMA Journal

Volumn 5, Issue 1, 2014, Pages

  Golubnitschaja, Olga ^a,b   Kinkorova, Judita ^b,c   Costigliola, Vincenzo ^b,d  

^a UNIVERSITY OF BONN   (Germany)

^b European Association for Predictive   (Belgium)

^c INSTITUTE OF MATHEMATICS   (Czech Republic)

^d European Medical Association   (Belgium)

Author keywords

Economy; Education; Ethics; Excellent science and technological innovation; Health care; Horizon 2020; Industrial leadership; Integrative bioinformatics; Predictive; Preventive and personalised medicine; Societal challenges

Indexed keywords

AGING; ARTICLE; BIOBANKING; BIOINFORMATICS; BIOPRESERVATION; CLINICAL COMPETENCE; CLINICAL DECISION MAKING; DATA ANALYSIS; EVIDENCE BASED MEDICINE; EXPERIMENTAL THERAPY; HEALTH CARE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; HUMAN RELATION; INDEPENDENT LIVING; INTEGRATIVE MEDICINE; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL RECORD; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; PATIENT CARE; PATIENT PARTICIPATION; PERSONALIZED MEDICINE; PRESERVATION AND STORAGE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; PUBLICATION; SCREENING; STANDARDIZATION; WELLBEING; WORK ENVIRONMENT;

EID: 84927773122     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1186/1878-5085-5-6     Document Type: Article

References (35)

1. Advances in Predictive, Preventive and Personalised Medicine. [http://www.springer.com/series/10051].
2. Golubnitschaja O. Time for new guidelines in advanced diabetes care: paradigm change from delayed interventional approach to predictive, preventive & personalized medicine. EPMA J 2010, 1:3-12. 10.1007/s13167-010-0014-5, 3405298, 23199036.
3. Norstedt I. Horizon 2020: European perspectives in healthcare sciences and implementation. EPMA J 2014, 5:A1.
4. Golubnitschaja O, Swanton C, Danesi R, Costigliola V. Promoting predictive, preventive and personalised medicine: European event of global importance. EPMA J 2011, 2:131-136. 3405384, 23199141.
5. Golubnitschaja O, Costigliola V, . EPMA General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J 2012, 1(1):14. EPMA.
6. EPMA Summit and World Congress 2013 in Brussels: European Association for Predictive, Preventive and Personalised Medicine develops a new culture in communication amongst stakeholders. [http://www.epmanet.eu/images/stories/pdfs/EPMA%20Summit%20and%20World%20Congress%202013_press%20release_Oct%202013.pdf].
7. The EU Framework Programme for Research and Innovation - health, demographic change and wellbeing. [http://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing].
8. The EU Framework Programme for Research and Innovation - What is Horizon 2010?. [http://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020].
9. Innovation Unit - a Europe 2020 Initiative. [http://ec.europa.eu/research/innovation-union/index_en.cfm].
10. Golubnitschaja O, Yeghiazaryan K. Opinion controversy to chromium picolinate therapy's safety and efficacy: ignoring " anecdotes" of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?. EPMA J 2012, 3:11. 10.1186/1878-5085-3-11, 3515400, 23039227.
11. Golubnitschaja O. Three levels of prediction, prevention & individualised treatment algorithms to advance diabetes care: integrative approach. New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM 2013, 15-28. Dordrecht, Heidelberg, New York, London: Springer, Mozaffari MS, ISBN 978-94-007-5970-1.
12. Golubnitschaja O. Diabetes mellitus. Predictive Diagnostics and Personalized Treatment: Dream or Reality? 2009, New York: Nova Science, Golubnitschaja O, 147-150, ISBN 978-1-60692-737-3.
13. Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, Kuhn W, Schild HH. Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?. EPMA J 2013, 4:6. 10.1186/1878-5085-4-6, 3615949, 23418957.
14. Golubnitschaja O, Yeghiazaryan K, Cebioglu M, Morelli M, Herrera-Marschitz M. Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care. EPMA J 2011, 2:197-210. 10.1007/s13167-011-0087-9, 3405378, 23199149.
15. Yeghiazaryan K, Flammer J, Golubnitschaja O. Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J 2010, 1:263-272. 10.1007/s13167-010-0032-3, 3405317, 23199064.
16. Golubnitschaja O, Yeghiazaryan K, Flammer J. Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?. EPMA J 2010, 1:237-244. 10.1007/s13167-010-0031-4, 3405318, 23199062.
17. Yeghiazaryan K, Flammer J, Golubnitschaja O. Individual predispositions in healthy vasospastic individuals: patient profiling for targeted prevention of " down-stream" pathologies as cost-effective personalised medicine. Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future 2013, 13-29. Dordrecht, Heidelberg, New York, London: Springer, Mandel S, ISBN 978-94-007-5865-0.
18. Golubnitschaja O, Yeghiazaryan K, Wunderlich K, Schild HH, Flammer J. Disease proteomics reveals altered basic gene expression regulation in leukocytes of normal-tension and primary open-angle glaucoma patients. Proteomics Clin Appl 2007, 1:1316-1323. 10.1002/prca.200700150, 21136628.
19. Golubnitschaja O. Neurodegeneration: accelerated ageing or inadequate healthcare?. EPMA J 2010, 1:211-215. 10.1007/s13167-010-0030-5, 3405328, 23199059.
20. Golubnitschaja O, Watson ID, Topic E, Sandberg S, Ferrari M, Costigliola V. Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care. EPMA J 2013, 4:12. 10.1186/1878-5085-4-12, 3700840, 23663422.
21. HORIZON 2020 - WORK PROGRAMME 2014 - 2015. [http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/main/h2020-wp1415-health_en.pdf].
22. Research & Innovation - Horizon 2020 Funding. [https://ec.europa.eu/research/participants/portal/desktop/en/home.html].
23. Costigliola V, Gahan P, Golubnitschaja O. Predictive medicine as the new philosophy in health care. Predictive Diagnostics and Personalized Treatment: Dream or Reality 2009, 1-3. New York: Nova Science, Golubnitschaja O, ISBN 978-1-60692-737-3.
24. Golubnitschaja O. Changing long-held beliefs is never easy: a proposal for multimodal approaches in female healthcare - an integrative view. Healthcare Overview: New Perspectives 2012, 251-268. Dordrecht, Heidelberg, New York, London: Springer, Costigliola V, ISBN 978-94-007-4602-2.
25. Costigliola V. Mobility of medical doctors as an attribute of the cross-border healthcare: challenges, opportunities and perspectives. Healthcare Overview: New Perspectives 2012, 233-244. Dordrecht, Heidelberg, New York, London: Springer, Costigliola V, ISBN 978-94-007-4602-2.
26. Carlsen S, Petersen PH, Skeie S, Skadberg T, Sandberg S. Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med 2011, 49:1501-1507.
27. Kapalla M, Matuskova D. Information systems as an essential component of prediction in the laboratory diagnostics. Predictive Diagnostics and Personalized Treatment: Dream or Reality 2009, 529-548. New York: Nova Science, Golubnitschaja O.
28. Mandel S, Golubnitschaja O. Time for new guidelines in handling of neurodegenerative disorders: optimistic versus pessimistic prognosis by application of PPPM. Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future 2013, 3-9. Dordrecht, Heidelberg, New York, London: Springer, Mandel S.
29. Shapira N. A gender-specific nutritional approach to women's healthcare. Healthcare Overview: New Perspectives 2012, 269-305. Dordrecht, Heidelberg, New York, London: Springer, Costigliola V.
30. Marcus-Kalish M. Simultaneous systematic approach to enable predictive, preventive and personalised medicine - women healthcare as a case study. Healthcare Overview: New Perspectives 2012, 313-331. Dordrecht, Heidelberg, New York, London: Springer, Costigliola V.
31. Drucker E, Krapfenbauer K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J 2013, 4:7. 10.1186/1878-5085-4-7, 3599714, 23442211.
32. Kapalla M. Healthcare information complexity and the role of informatics in predictive, preventive and personalized medicine. Personalisierte Medizin 2010, 83-108. Dresden: Health Academy, Niederlag W, Lemke HU, Golubnitschaja O, Rienhoff O.
33. Gefenas E, Cekanauskaite A, Tuzaite E, Dranseika V, Characiejus D. New Ethical Paradigm in Preventive, Predictive and Personalised Medicine. Healthcare Overview: New Perspectives 2012, 471-484. Dordrecht, Heidelberg, New York, London: Springer, Costigliola V, ISBN 978-94-007-4602-2.
34. Society for Participatory Medicine. [http://participatorymedicine.org/].
35. The EPMA Journal. [http://www.epmajournal.com/].